Abstract
Binding of (+)‐[11C]DTBZ (dihydrotetrabenazine) to the striatal vesicular monoamine transporter (VMAT2) is widely considered to be a stable marker of dopamine neurone integrity. However, we now find that specific binding of a tracer dose of (+)‐[11C]DTBZ is modestly increased in rat striatum following dopamine depletion with α‐methyl‐p‐tyrosine (α‐MPT, +14%) or d‐amphetamine (d‐AMPH, 20 mg/kg, +12%) and decreased following dopamine elevation with γ‐hydroxybutyrate (GHB, −16%) or levodopa (−20%). We suggest that in vivo (+)‐[11C]DTBZ binding in imaging studies is subject to competition by vesicular dopamine and, in this respect, is not a “stable” dopamine biomarker as is generally assumed. Synapse 62:873–876, 2008.

This publication has 14 references indexed in Scilit: